BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 13.3//EN BEGIN:VTIMEZONE TZID:W. Europe Standard Time BEGIN:STANDARD DTSTART:20231002T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=3;BYMINUTE=0;BYMONTH=10 TZNAME:W. Europe Standard Time TZOFFSETFROM:+0200 TZOFFSETTO:+0100 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:W. Europe Daylight Time TZOFFSETFROM:+0100 TZOFFSETTO:+0200 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:\n\n\n \; \;\nKlaas Kiesewetter\, MA\, Specialist\, Tec hnology Assessment\, Business Unit VIBRANT\n\n\n\n \; \;\nMartin Z immerling\, Dr. rer. nat. Head of Implant Development\, R&\;D\n\n\n&nbs p\;\n\n\n\n\nThis webinar explains the difference between MRI scanning of a patient with a BONEBRIDGE in comparison to a patient with an OSIA implan t. What are the technical\, clinical\, and practical implications of an MR I scan in patients implanted with an active transcutaneous BCI? And what a re the health and economic aspects of MRI compatibility in active transcu taneous BCIs? DTEND:20230321T133000Z DTSTAMP:20240329T130826Z DTSTART:20230321T130000Z LOCATION: SEQUENCE:0 SUMMARY:CANCELED - MED-EL Webinar: BONEBRIDGE vs. OSIA with New OSIA MRI Ki t UID:RFCALITEM638473145066638289 X-ALT-DESC;FMTTYPE=text/html: